Q&A on practical aspects related to the implementation of the gradual roll-out of Eudamed pursuant to the MDR and IVDR, as amended by Regulation (EU) 2024/1860 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices1

欧盟 · 最近核对:2026-09-08

编号
Gradual roll out of EUDAMED
类型
指南
颁布机关
European Commission, DG Health and Food Safety
状态
in_force
主管机构
欧盟委员会 / MDCG

这份文件管什么

欧盟委员会器械领域指导文件,属「EUDAMED」专题,委员会指南清单页标注的发布时间为 November 2024;内容为「Q&A on practical aspects related to the implementation of the gradual roll-out of Eudamed pursuant to the MDR and IVDR, as amended by Regulation (EU) 2024/1860 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices1」。此类文件无强制法律效力,但代表成员国主管当局与公告机构对 MDR/IVDR 的共同解释口径。注意 effective 填的是发布月份(日补 01),不是法律生效日。

官方原文: https://health.ec.europa.eu/document/download/0e7327c7-0e06-4fbd-90d3-8ab7bb30

© 欧盟,来源:EUR-Lex / 欧盟委员会。本站对原文的处理:{changes}

本页只陈述事实,不构成法律意见。以官方现行文本为准;本站不保证时效性,使用前请核对官方版本。